Microsoft-Yahoo Deal Underperforms and 2 Dow Movers to Follow
Merck & Co. (NYSE:MRK): Current price $41.17
The firm has finished a preliminary evaluation of the impact of the Venezuelan government’s plan to devalue its currency effective Wednesday. As a result of the move, Merck will incur a one time after-tax loss due to foreign exchange of about 5 cents per share in the first quarter connected to the remeasurement of the local balance sheet at the date of the devaluation. What is more, the company anticipates that the impact of the devaluation on ongoing operations should be roughly 2 cents per share, spread over the balance of the year. However, the effects of the devaluation do not alter Merck’s full year 2013 GAAP or full year non-GAAP EPS guidance ranges.
Microsoft Corporation (NASDAQ:MSFT): Current price $27.95
Yahoo! (NASDAQ:YHOO) Chief Executive Marissa Mayer says that her firm’s search arrangement with Microsoft is underperforming, and thus has not delivered the expected market share gains or revenue boost, according to TechCrunch, citing comments heard at the Goldman Sachs Technology and Internet Conference.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Wal-Mart Stores (NYSE:WMT): Current price $71.26
Back in 2007, Wal-Mart showcased its plans to launch up to 2,000 in-house medical clinics by mid-2012. Presently, there exist fewer than 130 clinics and the company is shutting locations faster than it opens them.
Don’t Miss: Can Yahoo Transform Into a Mobile Company?